Ginette Dubuc
National Research Council
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Ginette Dubuc.
Journal of Immunological Methods | 2002
Jamshid Tanha; Ginette Dubuc; Tomoko Hirama; Saran A. Narang; C. Roger MacKenzie
A llama single domain antibody (dAb) library designed and constructed to contain only heavy chain antibody variable domains (V(H)Hs) also contained a substantial number of typical conventional antibody heavy chain variable sequences (V(H)s). Panning the library against two carbohydrate-specific antibodies yielded anti-idiotypic dAbs and enriched solely for sequences from the V(H) subpopulation of the library. The conventional antibody origin of these V(H)s was confirmed by using oligonucleotide probes, specific for the enriched V(H)s, to identify the parental sequences in the message employed in library construction. Surprisingly, these V(H) dAbs, which are produced in high yield in Escherichia coli, are highly soluble, have excellent temperature stability profiles and do not display any aggregation tendencies. The very close similarity of these molecules to human V(H)s makes them potentially very useful as therapeutic dAbs.
Gene | 1991
N.N. Anand; Ginette Dubuc; J. Phipps; C.R. MacKenzie; J. Sadowska; N.M. Young; David R. Bundle; Saran A. Narang
A 1460-bp DNA encoding the two chains of the antigen-binding fragment (Fab) portion of a monoclonal antibody have been chemically synthesized and expressed in Escherichia coli. The antibody, Se155-4, is specific for a Salmonella serogroup B O-antigen and its crystal structure is under investigation. The genes were synthesized according to a strategy that allows for easy manipulation in genetic engineering studies of the Fab-binding site. Each gene is preceded by the ompA secretory signal and a ribosome-binding site, and has been expressed from the two-cistron DNA under the control of the lac promoter. Active Fab of 50 kDa with an inter-chain disulfide bond has been isolated from the periplasm of E. coli in a one-step affinity purification in high yield (2 micrograms/ml of cells). The bacterially produced Fab is as active as purified mouse Fab in antigen-binding and competitive immunoassays. This is the first example of a completely synthetic Fab gene and provides an ideal system to probe the nature of antigen binding by anti-carbohydrate antibodies.
Immunotechnology | 1995
C. Roger MacKenzie; Ian D. Clark; Stephen V. Evans; Irene E. Hill; John P. MacManus; Ginette Dubuc; David R. Bundle; Saran A. Narang; N. Martin Young; Arthur G. Szabo
The combination of an antibody fragment with a lanthanide chelating protein has desirable characteristics for fluorescence-based immunoassays and tumor radioimmunotherapy. As a model for this design, a fusion protein consisting of a single-chain antibody linked to an engineered version of oncomodulin, a protein with two Ca(2+)-binding motifs (the CD and EF loops), was produced by secretion from Escherichia coli in good yield. The single-chain antibody was specific for a Salmonella O-polysaccharide. The CD loop of oncomodulin had been redesigned to bind lanthanide ions with high affinity. The fusion protein was shown to have antigen-binding activity that was comparable to that of the unfused single-chain antibody, to bind Tb3+ with very high affinity and to give strong, sensitized Tb3+ luminescence via excitation of the tryptophan residue in the CD loop. A second fusion protein containing a 30-residue helix-loop-helix motif as the lanthanide-binding component was also prepared, but showed considerably lower solubility. Competition for Tb3+ binding by a series of metal chelators indicated that the affinities of the oncomodulin and 30 residue fusions for Tb3+ were approximately 10(11) M-1 and 10(7) M-1, respectively. Time-resolved lanthanide luminescence photography of electrophoresis gels demonstrated that the helix-loop-helix Ca(2+)-binding could be used to specifically visualize the scFv fragment.
Gene | 1986
Thomas A. Patterson; Donald L. Court; Ginette Dubuc; Joseph Michniewicz; J. Goodchild; Ahmad I. Bukhari; Saran A. Narang
We describe below the chemical synthesis of the right and left ends of bacteriophage Mu and characterize the activity of these synthetic ends in mini-Mu transposition. Mini-Mu plasmids were constructed which carry the synthetic Mu ends together with the Mu A and B genes under control of the bacteriophage lambda pL promoter. Derepression of pL leads to a high frequency of mini-Mu transposition (5.6 X 10(-2) which is dependent on the presence of the Mu ends and the Mu A and B proteins. Five deletion mutants in the Mu ends were tested in the mini-Mu transposition system and their effects on transposition are described.
Biochemical and Biophysical Research Communications | 1986
Saran A. Narang; Ginette Dubuc; Fei-Long Yao; Joseph Michniewicz
Without prior in vitro enzymatic ligation a DNA duplex was assembled successfully by directly transforming competent cells with a mixture containing six synthetic complimentary oligodeoxyribonucleotides and a linearized plasmid. One out of 100 transformants was positive in colony hybridization with one of the synthetic fragment probe. The sequence of the DNA duplex inserted into the plasmid was confirmed by dideoxy sequencing method.
Archive | 2001
Jamshid Tanha; Ginette Dubuc; Saran A. Narang
Journal of Immunological Methods | 2005
Kerrm Y. Yau; Ginette Dubuc; Shenghua Li; Tomoko Hirama; C. Roger MacKenzie; Lutz Jermutus; J. Christopher Hall; Jamshid Tanha
Gene | 1982
David Y. Thomas; Ginette Dubuc; Saran A. Narang
Nature Biotechnology | 1994
C. Roger MacKenzie; Vidhya Sharma; David A. Brummell; Doris Bilous; Ginette Dubuc; Joanna M. Sadowska; N. Martin Young; David R. Bundle; Saran A. Narang
Analytica Chimica Acta | 2001
Jianquan Wang; C. Mark Ensor; Ginette Dubuc; Saran A. Narang; Sylvia Daunert